ADAPTIMMUNE THERAPEUTICS ADR COM
ADAPTIMMUNE THERAPEUTICS ADR COM is a security (CUSIP 00653A107) tracked across SEC portfolio filings. 2 institutional managers reported $72 on Form 13F as of 2026-03-31; 1 registered fund positions totaling $2 via N-PORT as of 2026-05-29.
Summary
- Issuer: ADAPTIMMUNE THERAPEUTICS ADR
- Class: COM
- CUSIP: 00653A107
- Asset category: EC
- 13F holders: 2
- 13F value: $72
- 13F period: 2026-03-31
- N-PORT fund positions: 1
- N-PORT value: $2
- N-PORT report: 2026-05-29
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| RHUMBLINE ADVISERS | BOSTON, MA | $72 | 3,661 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
| Fund | Registrant | Value | % of fund |
|---|
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $2 | 0.00% |
More